CNBC

FDA withdraws Covid antibody treatment Evusheld because it's not effective against 93% of subvariants

The FDA pulled Evusheld from the market because it is not effective against more than 90% of the Covid subvariants that are currently circulating in the U.S. People with compromised immune systems, ...
Yahoo

Without Evusheld, Immunocompromised People Are on Their Own Against COVID-19

When it comes to avoiding COVID-19 in the U.S., it’s increasingly everyone for themselves. The Biden Administration announced it will end pandemic emergency declarations in May 2023, which will affect ...
ABC7

FDA halts authorization of Evusheld, citing medication insufficient against viral COVID-19 variants

The US Food and Drug Administration on Thursday halted the emergency use authorization of Evusheld because it does not appear to protect against COVID-19 from viral variants currently circulating in ...
STAT

FDA pulls Evusheld authorization as coronavirus evolution quashes another therapy

The evolution of the coronavirus has knocked out another treatment. The Food and Drug Administration on Thursday withdrew the authorization of Evusheld, the latest antibody therapy to be rendered ...